Vireo Growth (VREOF) Invested Capital (2020 - 2026)
Vireo Growth's (VREOF) quarterly Invested Capital came in at $295.4 million in Q1 2026, up 484.95% year-on-year from $50.5 million in Q1 2025, and down 8.74% quarter-over-quarter from $323.7 million in Q4 2025.
Vireo Growth (VREOF) Invested Capital (2020 - 2026) Analysis & Trends
Vireo Growth has disclosed Invested Capital across 7 years of filings, most recently posting $295.4 million for Q1 2026.
- Invested Capital for Q1 2026 came in at $295.4 million, up 484.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $295.4 million (up 484.95% YoY), and the FY2025 annual result was $323.7 million, up 472.92% from the prior year.
- Invested Capital came in at $295.4 million for Q1 2026 at Vireo Growth, down from $323.7 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $323.7 million in Q4 2025 to a low of -$9.9 million in Q3 2024.
- The 5-year median for Invested Capital is $50.5 million (2025), against an average of $99.2 million.
- Peak annual rise in Invested Capital reached 3800.96% in 2024, while the deepest fall reached 123.16% in 2024.
- Vireo Growth's Invested Capital stood at $15.2 million in 2022, then jumped by 190.24% to $44.2 million in 2023, then rose by 27.89% to $56.5 million in 2024, then soared by 472.92% to $323.7 million in 2025, then dropped by 8.74% to $295.4 million in 2026.
- The last three Invested Capital figures came in at $295.4 million (Q1 2026), $323.7 million (Q4 2025), and $246.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 10.84 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 3.23 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 5.90 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 479.60 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 3.41 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 10.24 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.78 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 446.17 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.79 Bn |
| 10 | Vireo Growth | - | - | 59.30 Mn | 295.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 295.40 Mn |
| Dec 31, 2025 | 323.70 Mn |
| Sep 30, 2025 | 246.47 Mn |
| Jun 30, 2025 | 295.06 Mn |
| Mar 31, 2025 | 50.50 Mn |
| Dec 31, 2024 | 56.50 Mn |
| Sep 30, 2024 | -9.86 Mn |
| Jun 30, 2024 | 38.94 Mn |
| Mar 31, 2024 | 38.32 Mn |
| Dec 31, 2023 | 44.18 Mn |
| Sep 30, 2023 | 42.58 Mn |
| Jun 30, 2023 | 45.95 Mn |
| Mar 31, 2023 | 982,346.00 |
| Dec 31, 2022 | 15.22 Mn |
| Sep 30, 2022 | 72.10 Mn |
| Jun 30, 2022 | 69.84 Mn |
| Mar 31, 2022 | 60.29 Mn |
| Dec 31, 2021 | 70.34 Mn |
| Sep 30, 2021 | 74.33 Mn |
| Jun 30, 2021 | 79.41 Mn |